PEARL Schizophrenia Maintenance

计划入组 676 人 · 首次发布于 2011 年 9 月 19 日

The PEARL 8.0 Post-Approval Study

计划入组 1 人 · 首次发布于 2013 年 5 月 3 日

Iron Bioavailability in Dana Shakti pearl millet

计划入组 60 人

Pearl (hyriopsis cumingii)

Pearl Dropping Pills

Opal (Cullinan Therapeutics)

Cullinan Pearl Corp.

United States

Cullinan Therapeutics

United States

Cullinan Mica Corp.

United States

Cullinan Oncology and Taiho Pharmaceutical Forge $275M Strategic Collaboration for EGFR Inhibitor CLN-081/TAS6417

PEARL Study: Durvalumab Monotherapy Shows Promise in NSCLC Patients with High PD-L1 Expression

Analysts Maintain Strong Buy Consensus on Cullinan Management (CGEM) with Significant Upside Potential